{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:45:27Z","timestamp":1791477927587,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Doctor Start-up Fund of Affiliated Hospital of Guizhou Medical University  to Bingxue Lan","award":["gyfybsky-2021-39"],"award-info":[{"award-number":["gyfybsky-2021-39"]}]},{"name":"the Cultivate project 2021 for National Natural Science Foundation of China, Guizhou Medical University  to Bingxue Lan","award":["21NSFCP05"],"award-info":[{"award-number":["21NSFCP05"]}]},{"name":"the Cultivate project 2021 for National Natural Science Foundation of China, the Affiliated Hospital of Guizhou Medical University to Bingxue Lan","award":["gyfynsfc-2021-11]"],"award-info":[{"award-number":["gyfynsfc-2021-11]"]}]},{"name":"the Foundation of the Education Department of Guizhou Province","award":["[2022]214"],"award-info":[{"award-number":["[2022]214"]}]},{"name":"the National Natural Science Foundation of China to hai huang","award":["No.82060442"],"award-info":[{"award-number":["No.82060442"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-69435-y","type":"journal-article","created":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T07:02:28Z","timestamp":1723791748000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Gypenoside inhibits gastric cancer proliferation by suppressing glycolysis via the Hippo pathway"],"prefix":"10.1038","volume":"14","author":[{"given":"Li","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingxue","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoumin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sixi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,16]]},"reference":[{"key":"69435_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"69435_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002467","author":"D Zeng","year":"2021","unstructured":"Zeng, D. et al. Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric cancer. J. Immunother. Cancer https:\/\/doi.org\/10.1136\/jitc-2021-002467 (2021).","journal-title":"J. Immunother. Cancer"},{"key":"69435_CR3","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.2147\/OTT.S189687","volume":"12","author":"Y Liu","year":"2019","unstructured":"Liu, Y. et al. Metabolic reprogramming results in abnormal glycolysis in gastric cancer: A review. Onco Targets Ther. 12, 1195\u20131204. https:\/\/doi.org\/10.2147\/OTT.S189687 (2019).","journal-title":"Onco Targets Ther."},{"key":"69435_CR4","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaw5473","author":"B Faubert","year":"2020","unstructured":"Faubert, B., Solmonson, A. & DeBerardinis, R. J. Metabolic reprogramming and cancer progression. Science https:\/\/doi.org\/10.1126\/science.aaw5473 (2020).","journal-title":"Science"},{"key":"69435_CR5","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: The next generation. Cell 144, 646\u2013674. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013 (2011).","journal-title":"Cell"},{"key":"69435_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova, N. N. & Thompson, C. B. The emerging Hallmarks of cancer metabolism. Cell Metab. 23, 27\u201347. https:\/\/doi.org\/10.1016\/j.cmet.2015.12.006 (2016).","journal-title":"Cell Metab."},{"key":"69435_CR7","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1172\/JCI69741","volume":"123","author":"JR Doherty","year":"2013","unstructured":"Doherty, J. R. & Cleveland, J. L. Targeting lactate metabolism for cancer therapeutics. J. Clin. Investig. 123, 3685\u20133692. https:\/\/doi.org\/10.1172\/JCI69741 (2013).","journal-title":"J. Clin. Investig."},{"key":"69435_CR8","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.3748\/wjg.v22.i6.2046","volume":"22","author":"L-W Yuan","year":"2016","unstructured":"Yuan, L.-W., Yamashita, H. & Seto, Y. Glucose metabolism in gastric cancer: The cutting-edge. World J. Gastroenterol. 22, 2046\u20132059. https:\/\/doi.org\/10.3748\/wjg.v22.i6.2046 (2016).","journal-title":"World J. Gastroenterol."},{"key":"69435_CR9","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.chembiol.2017.08.028","volume":"24","author":"A Luengo","year":"2017","unstructured":"Luengo, A., Gui, D. Y. & Vander Heiden, M. G. Targeting metabolism for cancer therapy. Cell Chem. Biol. 24, 1161\u20131180. https:\/\/doi.org\/10.1016\/j.chembiol.2017.08.028 (2017).","journal-title":"Cell Chem. Biol."},{"key":"69435_CR10","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1002\/ptr.7735","volume":"37","author":"C Guo","year":"2023","unstructured":"Guo, C. et al. Targeting lipid metabolism with natural products: A novel strategy for gastrointestinal cancer therapy. Phytother. Res. 37, 2036\u20132050. https:\/\/doi.org\/10.1002\/ptr.7735 (2023).","journal-title":"Phytother. Res."},{"key":"69435_CR11","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1038\/s41467-018-04999-8","volume":"9","author":"W Xiang","year":"2018","unstructured":"Xiang, W. et al. Monoacylglycerol lipase regulates cannabinoid receptor 2-dependent macrophage activation and cancer progression. Nat. Commun. 9, 2574. https:\/\/doi.org\/10.1038\/s41467-018-04999-8 (2018).","journal-title":"Nat. Commun."},{"key":"69435_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12894","volume":"53","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. Cellular senescence and cancer: Focusing on traditional Chinese medicine and natural products. Cell Prolif. 53, e12894. https:\/\/doi.org\/10.1111\/cpr.12894 (2020).","journal-title":"Cell Prolif."},{"key":"69435_CR13","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1055\/s-0030-1250186","volume":"76","author":"WL Hsiao","year":"2010","unstructured":"Hsiao, W. L. & Liu, L. The role of traditional Chinese herbal medicines in cancer therapy\u2013from TCM theory to mechanistic insights. Planta Med. 76, 1118\u20131131. https:\/\/doi.org\/10.1055\/s-0030-1250186 (2010).","journal-title":"Planta Med."},{"key":"69435_CR14","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/s2095-4964(14)60034-0","volume":"12","author":"Z-L Liu","year":"2014","unstructured":"Liu, Z.-L. et al. Traditional Chinese medicinal herbs combined with epidermal growth factor receptor tyrosine kinase inhibitor for advanced non-small cell lung cancer: A systematic review and meta-analysis. J. Integr. Med. 12, 346\u2013358. https:\/\/doi.org\/10.1016\/s2095-4964(14)60034-0 (2014).","journal-title":"J. Integr. Med."},{"key":"69435_CR15","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1142\/S0192415X14500359","volume":"42","author":"CY Wang","year":"2014","unstructured":"Wang, C. Y., Bai, X. Y. & Wang, C. H. Traditional Chinese medicine: A treasured natural resource of anticancer drug research and development. Am. J. Chin. Med. 42, 543\u2013559. https:\/\/doi.org\/10.1142\/S0192415X14500359 (2014).","journal-title":"Am. J. Chin. Med."},{"key":"69435_CR16","doi-asserted-by":"publisher","first-page":"1215150","DOI":"10.3389\/fphar.2023.1215150","volume":"14","author":"J-B Xie","year":"2023","unstructured":"Xie, J.-B. et al. Protective effect of heat-processed Gynostemma pentaphyllum on high fat diet-induced glucose metabolic disorders mice. Front. Pharmacol. 14, 1215150. https:\/\/doi.org\/10.3389\/fphar.2023.1215150 (2023).","journal-title":"Front. Pharmacol."},{"key":"69435_CR17","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/ptr.7639","volume":"37","author":"X Meng","year":"2023","unstructured":"Meng, X. et al. Increasing brain glucose uptake by Gypenoside LXXV ameliorates cognitive deficits in a mouse model of diabetic Alzheimer\u2019s disease. Phytother. Res. 37, 611\u2013626. https:\/\/doi.org\/10.1002\/ptr.7639 (2023).","journal-title":"Phytother. Res."},{"key":"69435_CR18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13020-016-0114-9","volume":"11","author":"Y Li","year":"2016","unstructured":"Li, Y., Lin, W., Huang, J., Xie, Y. & Ma, W. Anti-cancer effects of Gynostemma pentaphyllum (Thunb.) Makino (Jiaogulan). Chin. Med. 11, 43. https:\/\/doi.org\/10.1186\/s13020-016-0114-9 (2016).","journal-title":"Chin. Med."},{"key":"69435_CR19","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jep.2018.03.012","volume":"219","author":"SF Xing","year":"2018","unstructured":"Xing, S. F. et al. The inhibitory effect of gypenoside stereoisomers, gypenoside L and gypenoside LI, isolated from Gynostemma pentaphyllum on the growth of human lung cancer A549 cells. J. Ethnopharmacol. 219, 161\u2013172. https:\/\/doi.org\/10.1016\/j.jep.2018.03.012 (2018).","journal-title":"J. Ethnopharmacol."},{"key":"69435_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/cells9102308","author":"JH Park","year":"2020","unstructured":"Park, J. H., Pyun, W. Y. & Park, H. W. Cancer metabolism: Phenotype, signaling and therapeutic targets. Cells https:\/\/doi.org\/10.3390\/cells9102308 (2020).","journal-title":"Cells"},{"key":"69435_CR21","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/s41392-022-01191-9","volume":"7","author":"M Fu","year":"2022","unstructured":"Fu, M. et al. The Hippo signalling pathway and its implications in human health and diseases. Signal Transd. Target. Ther. 7, 376. https:\/\/doi.org\/10.1038\/s41392-022-01191-9 (2022).","journal-title":"Signal Transd. Target. Ther."},{"key":"69435_CR22","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1016\/j.cub.2007.10.039","volume":"17","author":"FD Camargo","year":"2007","unstructured":"Camargo, F. D. et al. YAP1 increases organ size and expands undifferentiated progenitor cells. Curr. Biol. 17, 2054\u20132060. https:\/\/doi.org\/10.1016\/j.cub.2007.10.039 (2007).","journal-title":"Curr. Biol."},{"key":"69435_CR23","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1158\/0008-5472.CAN-07-2696","volume":"68","author":"SW Chan","year":"2008","unstructured":"Chan, S. W. et al. A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells. Cancer Res. 68, 2592\u20132598. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-2696 (2008).","journal-title":"Cancer Res."},{"key":"69435_CR24","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.15252\/embj.201490379","volume":"34","author":"E Enzo","year":"2015","unstructured":"Enzo, E. et al. Aerobic glycolysis tunes YAP\/TAZ transcriptional activity. EMBO J. 34, 1349\u20131370. https:\/\/doi.org\/10.15252\/embj.201490379 (2015).","journal-title":"EMBO J."},{"key":"69435_CR25","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/ncb3113","volume":"17","author":"W Wang","year":"2015","unstructured":"Wang, W. et al. AMPK modulates Hippo pathway activity to regulate energy homeostasis. Nat. Cell Biol. 17, 490\u2013499. https:\/\/doi.org\/10.1038\/ncb3113 (2015).","journal-title":"Nat. Cell Biol."},{"key":"69435_CR26","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.yexcr.2016.10.018","volume":"349","author":"K Vali\u0161","year":"2016","unstructured":"Vali\u0161, K., Talacko, P., Grob\u00e1rov\u00e1, V., \u010cern\u00fd, J. & Nov\u00e1k, P. Shikonin regulates C-MYC and GLUT1 expression through the MST1-YAP1-TEAD1 axis. Exp. Cell Res. 349, 273\u2013281. https:\/\/doi.org\/10.1016\/j.yexcr.2016.10.018 (2016).","journal-title":"Exp. Cell Res."},{"key":"69435_CR27","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrc2620","volume":"9","author":"K Polyak","year":"2009","unstructured":"Polyak, K. & Weinberg, R. A. Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits. Nat. Rev. Cancer 9, 265\u2013273. https:\/\/doi.org\/10.1038\/nrc2620 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"69435_CR28","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.3748\/wjg.v21.i7.2058","volume":"21","author":"Q He","year":"2015","unstructured":"He, Q. et al. Mechanism of action of gypenosides on type 2 diabetes and non-alcoholic fatty liver disease in rats. World J. Gastroenterol. 21, 2058\u20132066. https:\/\/doi.org\/10.3748\/wjg.v21.i7.2058 (2015).","journal-title":"World J. Gastroenterol."},{"key":"69435_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0095609","volume":"9","author":"H Yan","year":"2014","unstructured":"Yan, H. et al. Anti-cancer effect and the underlying mechanisms of gypenosides on human colorectal cancer SW-480 cells. PLoS One 9, e95609. https:\/\/doi.org\/10.1371\/journal.pone.0095609 (2014).","journal-title":"PLoS One"},{"key":"69435_CR30","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1177\/0960327113497771","volume":"33","author":"H Yan","year":"2014","unstructured":"Yan, H., Wang, X., Wang, Y., Wang, P. & Xiao, Y. Antiproliferation and anti-migration induced by gypenosides in human colon cancer SW620 and esophageal cancer Eca-109 cells. Hum. Exp. Toxicol. 33, 522\u2013533. https:\/\/doi.org\/10.1177\/0960327113497771 (2014).","journal-title":"Hum. Exp. Toxicol."},{"key":"69435_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-023-02724-x","author":"H-Y Liu","year":"2023","unstructured":"Liu, H.-Y. et al. Bacoside a inhibits the growth of glioma by promoting apoptosis and autophagy in U251 and U87 cells. Naunyn Schmiedebergs Arch. Pharmacol. https:\/\/doi.org\/10.1007\/s00210-023-02724-x (2023).","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"69435_CR32","doi-asserted-by":"publisher","first-page":"5438","DOI":"10.1021\/acs.jafc.2c02512","volume":"70","author":"H Tan","year":"2022","unstructured":"Tan, H., Li, M., Han, L., Zhao, Y. & Zhang, X. Gypensapogenin I suppresses cell proliferation in triple-negative breast cancer via triggering the closure of AKT\/GSK3\u03b2\/\u03b2-catenin and notch-1 signaling pathways. J. Agric. Food Chem. 70, 5438\u20135449. https:\/\/doi.org\/10.1021\/acs.jafc.2c02512 (2022).","journal-title":"J. Agric. Food Chem."},{"key":"69435_CR33","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41419-018-0564-3","volume":"9","author":"Z He","year":"2018","unstructured":"He, Z. et al. MiR-422a regulates cellular metabolism and malignancy by targeting pyruvate dehydrogenase kinase 2 in gastric cancer. Cell Death Dis. 9, 505. https:\/\/doi.org\/10.1038\/s41419-018-0564-3 (2018).","journal-title":"Cell Death Dis."},{"key":"69435_CR34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2123231119","volume":"119","author":"H Yu","year":"2022","unstructured":"Yu, H. et al. Dual roles of \u03b2-arrestin 1 in mediating cell metabolism and proliferation in gastric cancer. Proc. Natl. Acad. Sci. U. S. A. 119, e2123231119. https:\/\/doi.org\/10.1073\/pnas.2123231119 (2022).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"69435_CR35","doi-asserted-by":"publisher","first-page":"152409","DOI":"10.1016\/j.prp.2019.04.001","volume":"215","author":"H Li","year":"2019","unstructured":"Li, H. et al. Pyruvate kinase M2 contributes to cell growth in gastric cancer via aerobic glycolysis. Pathol. Res. Pract. 215, 152409. https:\/\/doi.org\/10.1016\/j.prp.2019.04.001 (2019).","journal-title":"Pathol. Res. Pract."},{"key":"69435_CR36","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s13046-023-02827-6","volume":"42","author":"C Zhang","year":"2023","unstructured":"Zhang, C. et al. LncRNA CCAT1 facilitates the progression of gastric cancer via PTBP1-mediated glycolysis enhancement. J. Exp. Clin. Cancer Res. 42, 246. https:\/\/doi.org\/10.1186\/s13046-023-02827-6 (2023).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"69435_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12102819","author":"RM Pascale","year":"2020","unstructured":"Pascale, R. M., Calvisi, D. F., Simile, M. M., Feo, C. F. & Feo, F. The Warburg effect 97 years after its discovery. Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers12102819 (2020).","journal-title":"Cancers (Basel)"},{"key":"69435_CR38","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3322\/caac.21670","volume":"71","author":"DR Schmidt","year":"2021","unstructured":"Schmidt, D. R. et al. Metabolomics in cancer research and emerging applications in clinical oncology. CA Cancer J. Clin. 71, 333\u2013358. https:\/\/doi.org\/10.3322\/caac.21670 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"69435_CR39","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1038\/s41467-023-38360-5","volume":"14","author":"C Sun","year":"2023","unstructured":"Sun, C. et al. Spatially resolved multi-omics highlights cell-specific metabolic remodeling and interactions in gastric cancer. Nat. Commun. 14, 2692. https:\/\/doi.org\/10.1038\/s41467-023-38360-5 (2023).","journal-title":"Nat. Commun."},{"key":"69435_CR40","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41571-023-00729-2","volume":"20","author":"J Yang","year":"2023","unstructured":"Yang, J., Chen, Y., Jing, Y., Green, M. R. & Han, L. Advancing CAR T cell therapy through the use of multidimensional omics data. Nat. Rev. Clin. Oncol. 20, 211\u2013228. https:\/\/doi.org\/10.1038\/s41571-023-00729-2 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"69435_CR41","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1101\/gad.197582.112","volume":"26","author":"J-S Mo","year":"2012","unstructured":"Mo, J.-S., Yu, F.-X., Gong, R., Brown, J. H. & Guan, K.-L. Regulation of the Hippo-YAP pathway by protease-activated receptors (PARs). Genes Dev. 26, 2138\u20132143. https:\/\/doi.org\/10.1101\/gad.197582.112 (2012).","journal-title":"Genes Dev."},{"key":"69435_CR42","doi-asserted-by":"publisher","first-page":"4303","DOI":"10.1111\/cas.15079","volume":"112","author":"K Nakatani","year":"2021","unstructured":"Nakatani, K. et al. Alantolactone is a natural product that potently inhibits YAP1\/TAZ through promotion of reactive oxygen species accumulation. Cancer Sci. 112, 4303\u20134316. https:\/\/doi.org\/10.1111\/cas.15079 (2021).","journal-title":"Cancer Sci."},{"key":"69435_CR43","doi-asserted-by":"publisher","first-page":"8357","DOI":"10.1038\/ncomms9357","volume":"6","author":"Z Meng","year":"2015","unstructured":"Meng, Z. et al. MAP4K family kinases act in parallel to MST1\/2 to activate LATS1\/2 in the Hippo pathway. Nat. Commun. 6, 8357. https:\/\/doi.org\/10.1038\/ncomms9357 (2015).","journal-title":"Nat. Commun."},{"key":"69435_CR44","doi-asserted-by":"publisher","first-page":"119201","DOI":"10.1016\/j.bbamcr.2021.119201","volume":"1869","author":"U Lee","year":"2022","unstructured":"Lee, U., Cho, E.-Y. & Jho, E.-H. Regulation of Hippo signaling by metabolic pathways in cancer. Biochim. Biophys. Acta Mol. Cell Res. 1869, 119201. https:\/\/doi.org\/10.1016\/j.bbamcr.2021.119201 (2022).","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"69435_CR45","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.biopha.2017.08.091","volume":"95","author":"C Lin","year":"2017","unstructured":"Lin, C. & Xu, X. YAP1-TEAD1-Glut1 axis dictates the oncogenic phenotypes of breast cancer cells by modulating glycolysis. Biomed. Pharmacother. 95, 789\u2013794. https:\/\/doi.org\/10.1016\/j.biopha.2017.08.091 (2017).","journal-title":"Biomed. Pharmacother."},{"key":"69435_CR46","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1002\/hep.29663","volume":"67","author":"R Chen","year":"2018","unstructured":"Chen, R. et al. High mobility group protein B1 controls liver cancer initiation through yes-associated protein-dependent aerobic glycolysis. Hepatology 67, 1823\u20131841. https:\/\/doi.org\/10.1002\/hep.29663 (2018).","journal-title":"Hepatology"},{"key":"69435_CR47","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s12672-023-00709-z","volume":"14","author":"X Li","year":"2023","unstructured":"Li, X. et al. GPR81-mediated reprogramming of glucose metabolism contributes to the immune landscape in breast cancer. Discov. Oncol. 14, 140. https:\/\/doi.org\/10.1007\/s12672-023-00709-z (2023).","journal-title":"Discov. Oncol."},{"key":"69435_CR48","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2018100294","author":"AG Cox","year":"2018","unstructured":"Cox, A. G. et al. Yap regulates glucose utilization and sustains nucleotide synthesis to enable organ growth. EMBO J. https:\/\/doi.org\/10.15252\/embj.2018100294 (2018).","journal-title":"EMBO J."},{"key":"69435_CR49","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s13046-018-0892-2","volume":"37","author":"X Zhang","year":"2018","unstructured":"Zhang, X. et al. Yes-associated protein (YAP) binds to HIF-1\u03b1 and sustains HIF-1\u03b1 protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress. J. Exp. Clin. Cancer Res. 37, 216. https:\/\/doi.org\/10.1186\/s13046-018-0892-2 (2018).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"69435_CR50","doi-asserted-by":"publisher","first-page":"225","DOI":"10.7150\/ijbs.75459","volume":"19","author":"H Song","year":"2023","unstructured":"Song, H. et al. HIF-1\u03b1\/YAP signaling rewrites glucose\/iodine metabolism program to promote papillary thyroid cancer progression. Int. J. Biol. Sci. 19, 225\u2013241. https:\/\/doi.org\/10.7150\/ijbs.75459 (2023).","journal-title":"Int. J. Biol. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-69435-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-69435-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-69435-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T07:09:31Z","timestamp":1723792171000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-69435-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,16]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["69435"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-69435-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4044751\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,16]]},"assertion":[{"value":"8 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19003"}}